Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Anastasiya L Oshchepkova"'
Autor:
Gera A Pavlova, Julia V Popova, Evgeniya N Andreyeva, Lyubov A Yarinich, Mikhail O Lebedev, Alyona V Razuvaeva, Tatiana D Dubatolova, Anastasiya L Oshchepkova, Claudia Pellacani, Maria Patrizia Somma, Alexey V Pindyurin, Maurizio Gatti
Publikováno v:
PLoS Genetics, Vol 15, Iss 9, p e1008371 (2019)
The Drosophila Nonspecific Lethal (NSL) complex is a major transcriptional regulator of housekeeping genes. It contains at least seven subunits that are conserved in the human KANSL complex: Nsl1/Wah (KANSL1), Dgt1/Nsl2 (KANSL2), Rcd1/Nsl3 (KANSL3),
Externí odkaz:
https://doaj.org/article/74f0d8efc5954cc9885613dccef45182
Autor:
Anna A. Ogienko, Evgeniya N. Andreyeva, Evgeniya S. Omelina, Anastasiya L. Oshchepkova, Alexey V. Pindyurin
Publikováno v:
BMC Genetics, Vol 21, Iss S1, Pp 1-11 (2020)
Abstract Background The Drosophila central nervous system (CNS) is a convenient model system for the study of the molecular mechanisms of conserved neurobiological processes. The manipulation of gene activity in specific cell types and subtypes of th
Externí odkaz:
https://doaj.org/article/37ffbf2f062249189bde973034b2bed2
Autor:
Evgeniya N. Andreyeva, Anna A. Ogienko, Tatiana D. Dubatolova, Anastasiya L. Oshchepkova, Elena N. Kozhevnikova, Anton V. Ivankin, Gera A. Pavlova, Sergei A. Kopyl, Alexey V. Pindyurin
Publikováno v:
BMC Genetics, Vol 20, Iss S1, Pp 15-23 (2019)
Abstract Background Expression of the CNDP2 gene is frequently up- or down-regulated in different types of human cancers. However, how the product of this gene is involved in cell growth and proliferation is poorly understood. Moreover, our knowledge
Externí odkaz:
https://doaj.org/article/297d4be63a424110b06069fe6364bdfb
Autor:
Oleg V. Markov, Aleksandra V. Sen’kova, Islam S. Mohamed, Elena V. Shmendel, Mikhail A. Maslov, Anastasiya L. Oshchepkova, Evgeniy V. Brenner, Nadezhda L. Mironova, Marina A. Zenkova
Publikováno v:
Pharmaceutics; Volume 14; Issue 11; Pages: 2542
Cell-free antitumor vaccines represent a promising approach to immunotherapy of cancer. Here, we compare the antitumor potential of cell-free vaccines based on microvesicles derived from dendritic cells (DCs) with DC- and cationic-liposome-based vacc
Autor:
Evgeniya N. Andreyeva, A. A. Ogienko, Anastasiya L. Oshchepkova, Alexey V. Pindyurin, Evgeniya S. Omelina
Publikováno v:
BMC Genetics, Vol 21, Iss S1, Pp 1-11 (2020)
BMC Genetics
BMC Genetics
Background The Drosophila central nervous system (CNS) is a convenient model system for the study of the molecular mechanisms of conserved neurobiological processes. The manipulation of gene activity in specific cell types and subtypes of the Drosoph
Autor:
K. N. Morozova, Oleg Markov, Marina A. Zenkova, Anastasiya L. Oshchepkova, A. A. Chernonosov, Elena Kiseleva, Lyudmila Artemyeva, Evgeniy G. Evtushenko, Vera Matveeva, Valentin V. Vlassov
Publikováno v:
Pharmaceutics, Vol 13, Iss 1911, p 1911 (2021)
Pharmaceutics
Volume 13
Issue 11
Pharmaceutics
Volume 13
Issue 11
The main advantage of extracellular vesicles (EVs) as a drug carrier system is their low immunogenicity and internalization by mammalian cells. EVs are often considered a cell-specific delivery system, but the production of preparative amounts of EVs
Autor:
T. D. Dubatolova, Evgeniya N. Andreyeva, S. A. Kopyl, Anastasiya L. Oshchepkova, Gera A. Pavlova, Anton V. Ivankin, Elena N. Kozhevnikova, Alexey V. Pindyurin, A. A. Ogienko
Publikováno v:
BMC Genetics, Vol 20, Iss S1, Pp 15-23 (2019)
BMC Genetics
BMC Genetics
Background Expression of the CNDP2 gene is frequently up- or down-regulated in different types of human cancers. However, how the product of this gene is involved in cell growth and proliferation is poorly understood. Moreover, our knowledge of the f
Autor:
Marina A. Zenkova, Alexey Stepanov, Igor A. Yaroshevich, Dmitry V. Bagrov, Jia Xie, Oleg V. Markov, A.I. Sokolova, R. S. Kalinin, Sergey M. Deyev, V. M. Ukrainskaya, Victoria O. Shipunova, Elena Kulakovskaya, Michael Maschan, Dmitry Pershin, Richard A. Lerner, N.A. Podoplelova, Eugene G. Maksimov, Y.P. Rubtsov, A. G. Gabibov, S. S. Terekhov, Anastasiya L. Oshchepkova
Development of CAR-T therapy led to immediate success in the treatment of B cell leukemia and lymphoma. It also raised an opportunity to design new protocols to target solid tumors. Manufacturing of therapy-competent functional CAR-T cells needs robu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::eebffd5358b85892f8cfc4d00bb7776e
https://doi.org/10.1101/2021.03.18.435976
https://doi.org/10.1101/2021.03.18.435976
Autor:
Jia Xie, Hongkai Zhang, Igor A. Yaroshevich, Oleg Markov, Elena Kulakovskaya, Marina A. Zenkova, Eugene G. Maksimov, Anstasiia Sokolova, Victoria O. Shipunova, Rustam Ziganshin, Dmitry V. Bagrov, Anastasiya L. Oshchepkova, V. M. Ukrainskaya, Sergey M. Deyev, S. S. Terekhov, Alexey Stepanov, A. S. Chernov, Alexander G. Gabibov, Georgii B. Telegin, Yuri Rubtsov, Nadezhda Podoplelova, Michael Maschan, Richard A. Lerner, Dmitry Pershin
Publikováno v:
Small. 17:2102643
Development of CAR-T therapy led to immediate success in the treatment of B cell leukemia. Manufacturing of therapy-competent functional CAR-T cells needs robust protocols for ex vivo/in vitro expansion of modified T-cells. This step is challenging,
Publikováno v:
Frontiers in Pharmacology, Vol 10 (2019)
Frontiers in Pharmacology
Frontiers in Pharmacology
Dendritic cell (DC)-based anti-tumor vaccines have great potential for the treatment of cancer. To date, a large number of clinical trials involving DC-based vaccines have been conducted with a view to treating tumors of different histological origin